The DOI matches its Crossref record.
Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial
Abstract
SUMMARY: Background and aims: In a recent open trial we have shown the efficacy of long term intermittent administration of a poorly absorbable antibiotic (rifaximin) in obtaining symptomatic relief in uncomplicated diverticular disease of the colon. The aim of this double‐blind placebo‐controlled trial was to test our previous observations. Methods: One hundred and sixty‐eight outpatients with symptomatic uncomplicated diverticular disease were treated with fibre supplementation (glucomannan 2 g/day) plus rifaximin 400 mg b.d. for 7 days every month (84 patients), or with glucomannan 2 g/day plus placebo two tablets b.d. for 7 days every month (84 patients). Clinical evaluation was performed at admission and at three‐month intervals for 12 months. Results: After 12 months, 68.9 % of the patients treated with rifaximin were symptom‐free or mildly symptomatic, compared to 39.5% in the placebo group (P= 0.001). Symptoms such as bloating and abdominal pain or discomfort were primarily affected by antibiotic treatment when compared with placebo (P < 0.001). Conclusion: Rifaximin appears to be of some advantage in obtaining symptomatic relief in diverticular disease of the colon when compared with fibre supplementation alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pathogenesis of Helicobacter pylori Infection
Kusters, J. G., van Vliet, A. H. M., & Kuipers, E. J. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00054-05 · Cited by 2,526
Diverticular Disease of the Colon
Fox, J. M., & Stollman, N. H. (2010) · Sleisenger and Fordtran's Gastrointestinal and Liver Disease · doi:10.1016/b978-1-4160-6189-2.00117-7 · Cited by 820
Diagnosis and treatment of diverticular disease: Results of a consensus development conference
Köhler, L., Sauerland, S., Neugebauer, E., Caprilli, R., Fingerhut, A., Haboubi, N. Y., Hultén, L., Hüscher, C. G. S., Jansen, A., Kauczor, H.-U., et al. (1999) · Surgical Endoscopy · doi:10.1007/s004649901007 · Cited by 472
Ford, A. C., Yuan, Y., & Moayyedi, P. (2020) · Gut · doi:10.1136/gutjnl-2020-320839 · Cited by 464
A global assessment of the oesophageal adenocarcinoma epidemic
Edgren, G., Adami, H.-O., Weiderpass, E., & Nyrén, O. (2013) · Gut · doi:10.1136/gutjnl-2012-302412 · Cited by 347
Metadata
- Authors
- PAPI, C., CIACO, A., KOCH, M., & CAPURSO, L.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 9
- Issue
- 1
- Pages
- 33-39
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2165658880
- Cited by
- 187
- References
- 0
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial. https://app.cochat.ai/papers/10.1111/j.1365-2036.1995.tb00348.x
- The paper
- PAPI, C., CIACO, A., KOCH, M., & CAPURSO, L. (1995). Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double‐blind placebo‐controlled trial. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.1995.tb00348.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.